Some Prominent Doctors Continue to Shun Biogen's Alzheimer's Drug

·3-min read

Even if the FDA approves the drug, it could be hard to sell with key opinion leaders coming out against the therapy.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting